|
1
|
Williams E, Villar-Prados A, Bowser J,
Broaddus R and Gladden AB: Loss of polarity alters proliferation
and differentiation in low-grade endometrial cancers by disrupting
Notch signaling. PLoS One. 12:e01890812017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hatakeyama S: TRIM proteins and cancer.
Nat Rev Cancer. 11:792–804. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kulkarni A, Oza J, Yao M, Sohail H,
Ginjala V, Tomas-Loba A, Horejsi Z, Tan AR, Boulton SJ and Ganesan
S: Tripartite Motif-containing 33 (TRIM33) protein functions in the
poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response
through interaction with Amplified in Liver Cancer 1 (ALC1)
protein. J Biol Chem. 288:32357–32369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sedgwick GG, Townsend K, Martin A,
Shimwell NJ, Grand RJ, Stewart GS, Nilsson J and Turnell AS:
Transcriptional intermediary factor 1γ binds to the
anaphase-promoting complex/cyclosome and promotes mitosis.
Oncogene. 32:4622–4633. 2013. View Article : Google Scholar
|
|
6
|
Bai X, Kim J, Yang Z, Jurynec MJ, Akie TE,
Lee J, LeBlanc J, Sessa A, Jiang H, DiBiase A, et al: TIF1gamma
controls erythroid cell fate by regulating transcription
elongation. Cell. 142:133–143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen M, Lingadahalli S, Narwade N, Lei
KMK, Liu S, Zhao Z, Zheng Y, Lu Q, Tang AHN, Poon TCW and Cheung E:
TRIM33 drives prostate tumor growth by stabilizing androgen
receptor from Skp2-mediated degradation. EMBO Rep. 23:e534682022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Herquel B, Ouararhni K, Khetchoumian K,
Ignat M, Teletin M, Mark M, Béchade G, Van Dorsselaer A,
Sanglier-Cianférani S, Hamiche A, et al: Transcription cofactors
TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes
that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci
USA. 108:8212–8217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Y, Wu G, Zhang J, Li J, Ruan N, Zhang
J, Zhang Z, Chen Y, Zhang Q and Xia Q: TRIM33 overexpression
inhibits the progression of clear cell renal cell carcinoma in vivo
and in vitro. Biomed Res Int. 2020:84092392020.PubMed/NCBI
|
|
10
|
Dang CV, Le A and Gao P: MYC-induced
cancer cell energy metabolism and therapeutic opportunities. Clin
Cancer Res. 15:6479–6483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoffman B and Liebermann DA: Apoptotic
signaling by c-MYC. Oncogene. 27:6462–6472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Q, Xu P, Lu Y and Dou H: Correlation
of MACC1/c-Myc expression in endometrial carcinoma with
clinical/pathological features or prognosis. Med Sci Monit.
24:4738–4744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hawksworth D, Ravindranath L, Chen Y,
Furusato B, Sesterhenn IA, McLeod DG, Srivastava S and Petrovics G:
Overexpression of C-MYC oncogene in prostate cancer predicts
biochemical recurrence. Prostate Cancer Prostatic Dis. 13:311–315.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CH, Shen J, Lee WJ and Chow SN:
Overexpression of cyclin D1 and c-Myc gene products in human
primary epithelial ovarian cancer. Int J Gynecol Cancer.
15:878–883. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rochlitz CF, Herrmann R and de Kant E:
Overexpression and amplification of c-myc during progression of
human colorectal cancer. Oncology. 53:448–454. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Llombart V and Mansour MR: Therapeutic
targeting of 'undruggable' MYC. EBioMedicine. 75:1037562022.
View Article : Google Scholar
|
|
17
|
Gao P, Tchernyshyov I, Chang TC, Lee YS,
Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT and
Dang CV: c-Myc suppression of miR-23a/b enhances mitochondrial
glutaminase expression and glutamine metabolism. Nature.
458:762–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bott AJ, Peng IC, Fan Y, Faubert B, Zhao
L, Li J, Neidler S, Sun Y, Jaber N, Krokowski D, et al: Oncogenic
Myc induces expression of glutamine synthetase through promoter
demethylation. Cell Metab. 22:1068–1077. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HH, Wang YN, Xia W, Chen CH, Rau KM,
Ye L, Wei Y, Chou CK, Wang SC, Yan M, et al: Removal of N-Linked
Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1
Therapeutic Efficacy. Cancer Cell. 36:168–178.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Cassago A, Ferreira AP, Ferreira IM,
Fornezari C, Gomes ER, Greene KS, Pereira HM, Garratt RC, Dias SM
and Ambrosio AL: Mitochondrial localization and structure-based
phosphate activation mechanism of Glutaminase C with implications
for cancer metabolism. Proc Natl Acad Sci USA. 109:1092–1097. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Zhu J, Chen X, Xia H and Yang L:
E3 ubiquitin ligase Trim33 ubiquitylates Annexin A2 to promote
NF-κB induced skin inflammation in psoriasis. J Dermatol Sci.
107:160–168. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei T, Du Y, Shan T, Chen J, Shi D, Yang
T, Wang J, Zhang J and Li Y: The crystallin alpha B
(HSPB5)-tripartite motif containing 33 (TRIM33) axis mediates
myocardial fibrosis induced by angiotensinogen II through
transforming growth factor-β (TGF-β1)-Smad3/4 signaling.
Bioengineered. 13:8836–8849. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen Q, He T and Yuan H: Hsa_circ_0002577
promotes endometrial carcinoma progression via regulating
miR-197/CTNND1 axis and activating Wnt/β-catenin pathway. Cell
Cycle. 18:1229–1240. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gaglio D, Soldati C, Vanoni M, Alberghina
L and Chiaradonna F: Glutamine deprivation induces abortive s-phase
rescued by deoxyribonucleotides in k-ras transformed fibroblasts.
PLoS One. 4:e47152009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qing G, Li B, Vu A Skuli N, Walton ZE, Liu
X, Mayes PA, Wise DR, Thompson CB, Maris JM, et al: ATF4 regulates
MYC-mediated neuroblastoma cell death upon glutamine deprivation.
Cancer Cell. 22:631–644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Wang X, Su Y, Hu S and Chen J:
TRIM33 Modulates Inf lammation and Airway Remodeling of
PDGF-BB-Induced Airway Smooth-Muscle Cells by the Wnt/β-Catenin
Pathway. Int Arch Allergy Immunol. 183:1127–1136. 2022. View Article : Google Scholar
|
|
28
|
Marshall AD, van Geldermalsen M, Otte NJ,
Lum T, Vellozzi M, Thoeng A, Pang A, Nagarajah R, Zhang B, Wang Q,
et al: ASCT2 regulates glutamine uptake and cell growth in
endometrial carcinoma. Oncogenesis. 6:e3672017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiang Y, Stine ZE, Xia J, Lu Y, O'Connor
RS, Altman BJ, Hsieh AL, Gouw AM, Thomas AG, Gao P, et al: Targeted
inhibition of tumor-specific glutaminase diminishes cell-autonomous
tumorigenesis. J Clin Invest. 125:2293–2306. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Pavlova NN and Thompson CB:
Cancer cell metabolism: The essential role of the nonessential
amino acid, glutamine. EMBO J. 36:1302–1315. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sullivan LB, Gui DY, Hosios AM, Bush LN,
Freinkman E and Vander Heiden MG: Supporting aspartate biosynthesis
is an essential function of respiration in proliferating cells.
Cell. 162:552–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Birsoy K, Wang T, Chen WW, Freinkman E,
Abu-Remaileh M and Sabatini DM: An essential role of the
mitochondrial electron transport chain in cell proliferation is to
enable aspartate synthesis. Cell. 162:540–551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dominguez-Sola D, Ying CY, Grandori C,
Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J and
Dalla-Favera R: Non-transcriptional control of DNA replication by
c-Myc. Nature. 448:445–451. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Osthus RC, Shim H, Kim S, Li Q, Reddy R,
Mukherjee M, Xu Y, Wonsey D, Lee LA and Dang CV: Deregulation of
glucose transporter 1 and glycolytic gene expression by c-Myc. J
Biol Chem. 275:21797–21800. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wise DR, DeBerardinis RJ, Mancuso A, Sayed
N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon
SB and Thompson CB: Myc regulates a transcriptional program that
stimulates mitochondrial glutaminolysis and leads to glutamine
addiction. Proc Natl Acad Sci USA. 105:18782–18787. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xue J, Chen Y, Wu Y, Wang Z, Zhou A, Zhang
S, Lin K, Aldape K, Majumder S, Lu Z and Huang S: Tumour suppressor
TRIM33 targets nuclear β-catenin degradation. Nat Commun.
6:61562015. View Article : Google Scholar
|
|
38
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View Article : Google Scholar
|
|
39
|
Veliça P, Davies NJ, Rocha PP, Schrewe H,
Ride JP and Bunce CM: Lack of functional and expression homology
between human and mouse aldo-keto reductase 1C enzymes:
Implications for modelling human cancers. Mol Cancer. 8:1212009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou WJ, Zhang J, Yang HL, Wu K, Xie F, Wu
JN, Wang Y, Yao L, Zhuang Y, Xiang JD, et al: Estrogen inhibits
autophagy and promotes growth of endometrial cancer by promoting
glutamine metabolism. Cell Commun Signal. 17:992019. View Article : Google Scholar : PubMed/NCBI
|
